Galecto is a biotechnology company focused on the development of therapeutics for fibrotic disease and cancer. The company conducts research and clinical development activities related to small-molecule drug candidates.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!